subject: UMLS:C4688466


subject: UMLS:C4688466

subject_name: INCMGA 0012

object_name: grade 3B follicular lymphoma

tested_intervention: unsure


subject: PUBCHEM.COMPOUND:91820602

subject_name: Hyaluronidase

object_name: diffuse large B-cell lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: PUBCHEM.COMPOUND:91820602

object_name: high grade B-cell lymphoma


subject: PUBCHEM.COMPOUND:91820602


subject: UMLS:C1699394

subject_name: Hylenex


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UMLS:C1699394


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:166975

subject_name: soybean oil

object_name: heart disorder

tested_intervention: yes


subject: CHEBI:166975

object_name: Android obesity


subject: CHEBI:166975

object_name: Abdominal obesity


subject: CHEBI:166975

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:166975

object_name: metabolic syndrome X


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Lung Non-Small Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: AIDS-Related Non-Hodgkin Lymphoma


subject: UNII:DPT0O3T46P

object_name: Kaposi Sarcoma


subject: MESH:C000709231

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:70105374

subject_name: Pitavastatin Lactone

object_name: Inflammation


subject: PUBCHEM.COMPOUND:70105374

object_name: Increased reactive oxygen species production


subject: CHEBI:32020

subject_name: Pitavastatin


subject: CHEBI:32020


subject: UNII:N24015WC6D

subject_name: Atevirdine

object_name: AIDS


subject: PUBCHEM.COMPOUND:57414794

subject_name: Dolutegravir

object_name: Maternal-Fetal Infection Transmission


subject: PUBCHEM.COMPOUND:57414794

object_name: pregnancy related


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: ankylosing spondylitis


subject: UMLS:C4727210

subject_name: Cadonilimab


subject: UMLS:C4727210

object_name: gastric adenocarcinoma


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Solid Neoplasm


subject: CHEBI:49086

object_name: cannabis abuse


subject: CHEBI:16436

subject_name: Citicoline


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: acute kidney failure


subject: PUBCHEM.COMPOUND:92043599

object_name: Acute Kidney Injury, CTCAE


subject: PUBCHEM.COMPOUND:92043599

object_name: Surgical procedure finding


subject: PUBCHEM.COMPOUND:92043599

object_name: heart disorder


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: CHEBI:81579


subject: CHEBI:81579


subject: GTOPDB:4942

subject_name: GM-CSF

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UMLS:C0376563

subject_name: Recombinant Granulocyte-Macrophage Colony-Stimulating Factors


subject: UMLS:C3714648

subject_name: Vitamin K Drug Class

object_name: type 2 diabetes mellitus


subject: UMLS:C3541380

subject_name: Vitamin K containing hemostatics


subject: CHEBI:28384

subject_name: vitamin K


subject: CHEBI:18067

subject_name: Phylloquinone


subject: UMLS:C2936884

subject_name: Vitamin K [EPC]


subject: CHEBI:92769

subject_name: Iobenguane

object_name: ventricular tachycardia


subject: CHEBI:92769

object_name: Ventricular Tachycardia, CTCAE 3.0


subject: CHEBI:92769

object_name: continuous electrocardiogram ventricular tachycardia


subject: CHEBI:92769

object_name: Ventricular Tachycardia by ECG Finding


subject: CHEBI:92769

object_name: Ventricular Tachycardia, CTCAE 5.0


subject: CHEBI:92769

object_name: Arrhythmia


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: post operative nausea and vomiting


subject: UMLS:C4724855

subject_name: BCD 100

object_name: Nonsquamous nonsmall cell neoplasm of lung


subject: CHEBI:146178

subject_name: RACEMETHORPHAN

object_name: neurodegenerative disease


subject: CHEBI:146178

object_name: Parkinson disease


subject: CHEBI:146176

subject_name: levomethorphan


subject: CHEBI:146176


subject: CHEBI:4470

subject_name: Dextromethorphan


subject: CHEBI:4470


subject: CHEBI:83766

subject_name: Olaparib

object_name: HER2-Low Breast Carcinoma


subject: UNII:3XPI7EG4W8

subject_name: patritumab deruxtecan

object_name: Advanced breast cancer


subject: UNII:3XPI7EG4W8

object_name: Carcinoma breast stage IV


subject: UNII:3XPI7EG4W8


subject: UMLS:C4527158


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hemorrhage


subject: CHEBI:3215

object_name: paranasal sinus disorder


subject: CHEBI:3215

object_name: sinusitis


subject: CHEBI:28918

subject_name: Epinephrine


subject: CHEBI:28918


subject: CHEBI:83766

object_name: Locally Advanced Uterine Corpus Leiomyosarcoma


subject: CHEBI:83766

object_name: Stage III Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:83766

object_name: Metastatic Uterine Corpus Leiomyosarcoma


subject: CHEBI:83766

object_name: Stage IV Uterine Corpus Leiomyosarcoma AJCC v8


subject: CHEBI:83766

object_name: Unresectable Uterine Corpus Leiomyosarcoma


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: CHEBI:72564


subject: UMLS:C1996382

subject_name: Triple Cream

object_name: hyperpigmentation of the skin


subject: UMLS:C1996382

object_name: Hyperpigmentation, CTCAE


subject: UMLS:C1996382

object_name: varicosis


subject: CHEBI:184662

object_name: graft versus host disease


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:63608

subject_name: Maraviroc


subject: UMLS:C5237290

subject_name: T-Guard


subject: UMLS:C2355268

object_name: kidney neoplasm


subject: UMLS:C2355268

object_name: childhood kidney neoplasm


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED

object_name: psoriasis


subject: CHEBI:10110

subject_name: Zidovudine


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: small cell lung carcinoma


subject: UMLS:C2698851

subject_name: POMx

object_name: stroke disorder


subject: UMLS:C2698851

object_name: cerebrovascular disorder


subject: UMLS:C2698851

object_name: Stroke (heart beat)


subject: UMLS:C2698851

object_name: Stroke, CTCAE


subject: CHEBI:38290

subject_name: L-ascorbate

object_name: alcoholic hepatitis


subject: CHEBI:176783

subject_name: vitamin C


subject: UMLS:C3714687

subject_name: Vitamin C Drug Class


subject: UMLS:C2349136

subject_name: Vitamin C Vitamins


subject: CHEBI:22652

subject_name: Ascorbic acid


subject: UMLS:C4522080

subject_name: Vitamin C [EPC]


subject: UMLS:C5700342

object_name: Metastatic urothelial carcinoma


subject: CHEBI:91450

subject_name: Sapanisertib


subject: UNII:TWF0ML1CK8

subject_name: Fluzoparib

object_name: triple-negative breast carcinoma


subject: UNII:TWF0ML1CK8

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:291342

subject_name: Desloratadine

object_name: chronic idiopathic urticaria


subject: UMLS:C3827091

object_name: chronic hepatitis B virus infection


subject: UMLS:C3827091

object_name: chronic hepatitis D infection


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: CHEBI:59902

subject_name: ENTECAVIR


subject: CHEBI:473990

subject_name: Entecavir


subject: CHEBI:8502

subject_name: Propylthiouracil

object_name: endocrine exophthalmos


subject: CHEBI:8499

subject_name: Propranolol

object_name: esophageal varices


subject: UNII:0VCB95RHRV

subject_name: TAMNORZATINIB

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C4527012

subject_name: Axl/Mer Inhibitor ONO-7475


subject: PUBCHEM.COMPOUND:165363555

subject_name: Trikafta

object_name: Non-cystic fibrosis bronchiectasis


subject: UMLS:C5221269


subject: CHEBI:15864

subject_name: Luteolin

object_name: autism spectrum disorder


subject: CHEBI:57545


subject: CHEBI:57694


subject: CHEBI:16243

subject_name: Quercetin


subject: CHEBI:61606


subject: CHEBI:28527

subject_name: Rutin


subject: CHEBI:9932

subject_name: Vancomycin hydrochloride

object_name: congenital heart disease


subject: CHEBI:9932

object_name: aortic valve disorder


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:28001


subject: UMLS:C0205992

subject_name: vancomycin hydrochloride


subject: UMLS:C0205992


subject: PR:000010367

subject_name: lactadherin

object_name: obesity due to melanocortin 4 receptor deficiency


subject: PR:000010367

object_name: obesity


subject: PR:000010367

object_name: Obesity, CTCAE


subject: PR:000010367

object_name: abdominal obesity-metabolic syndrome


subject: PR:000010367

object_name: metabolic syndrome X


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Malignant neoplasm of stomach stage IV


subject: CHEBI:49603

object_name: Malignant neoplasm of stomach stage III


subject: CHEBI:49603

object_name: recurrent gastric cancer


subject: CHEBI:49603

object_name: Gastric Mixed Adenocarcinoma


subject: CHEBI:49603

object_name: diffuse gastric adenocarcinoma


subject: CHEBI:49603

object_name: gastric intestinal type adenocarcinoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Calcineurin inhibitor poisoning


subject: PUBCHEM.COMPOUND:54675783

subject_name: minocycline

object_name: Huntington disease


subject: HMDB:HMDB0256702

subject_name: Porfimer Sodium

object_name: malignant mesothelioma


subject: UNII:Y3834SIK5F

subject_name: PORFIMER SODIUM


subject: CHEBI:66903

subject_name: Vismodegib

object_name: adult medulloblastoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: Childhood Neuroblastoma


subject: UNII:4F4X42SYQ6

object_name: neuroblastoma


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: GTOPDB:13304

subject_name: datopotamab deruxtecan

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13304

object_name: breast carcinoma


subject: GTOPDB:13304

object_name: breast cancer


subject: GTOPDB:13304

object_name: Malignant neoplasm of female breast


subject: GTOPDB:13304

object_name: estrogen receptor-negative breast cancer


subject: GTOPDB:13304

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:13304

object_name: estrogen-receptor positive breast cancer


subject: GTOPDB:13304

object_name: Metastatic Triple-Negative Breast Carcinoma


subject: UNII:GD2OWY1DTK

subject_name: DATOPOTAMAB DERUXTECAN


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UNII:GD2OWY1DTK


subject: UMLS:C4726586

subject_name: ADC DS-1062a


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: UMLS:C4726586


subject: CHEMBL.COMPOUND:CHEMBL2108661

subject_name: VEHICLE

object_name: Skin and Connective Tissue Diseases


subject: PUBCHEM.COMPOUND:139291139

subject_name: Mineral oil


subject: UMLS:C1533712

subject_name: Heparanase inhibitor PI-88

object_name: melanoma


subject: CHEBI:9352

subject_name: Sulindac

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:9352

object_name: acute myeloid leukemia


subject: UMLS:C5784297

subject_name: KRAS G12D Degrader ASP3082

object_name: Childhood Solid Neoplasm


subject: UMLS:C5784297

object_name: Adult Solid Neoplasm


subject: UMLS:C5784297

object_name: Solid Neoplasm


subject: CHEBI:63724


subject: GTOPDB:13716

subject_name: disitamab vedotin

object_name: colorectal neoplasm


subject: UNII:RB3U3A1S27

subject_name: DISITAMAB VEDOTIN


subject: UMLS:C4329329


subject: CHEBI:10650

subject_name: Sumatriptan

object_name: migraine with aura


subject: CHEBI:7476

subject_name: Naproxen


subject: CHEBI:167574

subject_name: Semaglutide

object_name: chronic kidney disease


subject: CHEBI:167574

object_name: Chronic Kidney Disease, CTCAE


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE

object_name: tuberculosis


subject: UNII:L500PR95QA

object_name: multidrug-resistant tuberculosis


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: GTOPDB:9517

subject_name: atacicept

object_name: lupus nephritis


subject: CHEMBL.COMPOUND:CHEMBL1742986

subject_name: ATACICEPT


subject: UMLS:C2351058

subject_name: Atacicept


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: Deep thrombophlebitis


subject: UMLS:C2825026

object_name: Deep venous thrombosis


subject: UMLS:C2825026

object_name: osteoarthritis


subject: CHEBI:151315

subject_name: Heparin


subject: CHEBI:151315


subject: UNII:JTZ51LIXN4

subject_name: NEMTABRUTINIB

object_name: hematopoietic and lymphoid system neoplasm


subject: UNII:JTZ51LIXN4

object_name: Waldenstrom macroglobulinemia


subject: UNII:JTZ51LIXN4

object_name: non-Hodgkin lymphoma


subject: DRUGBANK:DB18866

subject_name: Nemtabrutinib


subject: DRUGBANK:DB18866


subject: DRUGBANK:DB18866


subject: CHEBI:6933

subject_name: Midodrine

object_name: septic shock


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: anti-glomerular basement membrane disease


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Pre T-ALL


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: Deficiency of vitamin D3


subject: CHEBI:89324

object_name: metabolic bone disorder


subject: CHEBI:89324

object_name: Stress (Physiology)


subject: CHEBI:89324

object_name: lung disorder


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:OS7097575K

subject_name: Parsaclisib

object_name: myelofibrosis


subject: UNII:OS7097575K

object_name: Post-polycythemia vera myelofibrosis


subject: UNII:OS7097575K


subject: UNII:6GNT3Y5LMF

subject_name: LEVOFLOXACIN

object_name: complications of organ transplant stem cells


subject: CHEBI:63598

subject_name: Levofloxacin


subject: CHEBI:6121

subject_name: Ketamine

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:6121

object_name: Fatigue


subject: CHEBI:6121

object_name: multiple sclerosis


subject: CHEBI:135307

subject_name: Moxaverine

object_name: benign neoplasm of retina


subject: CHEBI:135307

object_name: retinal cancer


subject: CHEBI:229764

subject_name: Selinexor

object_name: Lung squamous cell carcinoma recurrent


subject: CHEBI:229764

object_name: Stage IV Lung Squamous Cell Carcinoma AJCC v7


subject: CHEBI:4315

subject_name: Danazol

object_name: autoimmune thrombocytopenia


subject: CHEBI:4315

object_name: thrombocytopenia due to immune destruction


subject: CHEBI:4315

object_name: autoimmune thrombocytopenic purpura


subject: CHEBI:63610

subject_name: Misoprostol

object_name: gestational diabetes


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hernia


subject: UMLS:C0876183

subject_name: Thyrogen

object_name: nodular goiter


subject: CHEBI:81567

subject_name: Thyrotropin


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: lung cancer


subject: UMLS:C4086546

object_name: lung neoplasm


subject: UMLS:C4086546

object_name: lung carcinoma


subject: UMLS:C4086546

object_name: Neuromuscular inhibition


subject: PUBCHEM.COMPOUND:129735008

subject_name: SinuNase

object_name: chronic rhinosinusitis


subject: CHEBI:135857

subject_name: Bemotrizinol

object_name: absorption; chemicals


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Myocardial Infarction, CTCAE


subject: PUBCHEM.COMPOUND:73151030

object_name: Myocardial Infarction by ECG Finding


subject: CHEBI:6770

subject_name: MEROPENEM

object_name: Pseudomonas aeruginosa infection


subject: CHEBI:6770

object_name: pneumonia


subject: CHEBI:6770

object_name: COVID-19-Associated Pneumonia


subject: UMLS:C1314417

subject_name: INJECTION, MEROPENEM, 100 MG ADMINISTERED


subject: UMLS:C1314417


subject: UMLS:C1314417


subject: CHEBI:43968

subject_name: Meropenem


subject: CHEBI:43968


subject: CHEBI:43968


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: Dysphasia


subject: CHEBI:6888

object_name: specific language disorder


subject: CHEBI:6888

object_name: specific language impairment


subject: UMLS:C0718583

subject_name: Antioxidant Formula

object_name: female infertility


subject: CHEBI:138016

subject_name: MPA

object_name: endometrioid adenocarcinoma


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:17026

subject_name: Progesterone


subject: CHEBI:6715

subject_name: medroxyprogesterone


subject: PR:000012478

subject_name: rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha


subject: UniProtKB:P27664

subject_name: PDE6A_MOUSE Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha (sprot)


subject: CHEBI:52717

subject_name: Bortezomib

object_name: glycogen storage disease II


subject: CHEBI:93775

subject_name: Amethopterin


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:74947

subject_name: Thalidomide

object_name: mantle cell lymphoma


subject: CHEBI:5134

subject_name: Fluticasone

object_name: Nasal Polyp


subject: CHEBI:134964

subject_name: Perflubutane

object_name: Hepatic Mass


subject: CHEBI:134964

object_name: Metastatic malignant neoplasm to liver


subject: MESH:C069727

subject_name: Sonazoid


subject: MESH:C069727


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Myofacial Pain


subject: CHEBI:42797

subject_name: Gabapentin


subject: UMLS:C0795577

subject_name: recombinant antihemophilic factor VIII

object_name: blood coagulation disease


subject: UMLS:C1815180

subject_name: Kogenate FS


subject: UMLS:C0961271


subject: CHEBI:64816

object_name: lymphoblastic lymphoma


subject: CHEBI:64816

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:64816

object_name: Childhood Lymphoblastic Lymphoma


subject: CHEBI:64816

object_name: lymphoid leukemia


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:31822

subject_name: MERCAPTOPURINE


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:31822


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: UNII:7D96IR0PPM

subject_name: Pegaspargase


subject: UNII:7D96IR0PPM


subject: UNII:7D96IR0PPM


subject: UNII:FTK8U1GZNX

subject_name: THIOGUANINE


subject: UNII:FTK8U1GZNX


subject: UNII:FTK8U1GZNX


subject: CHEBI:9555

subject_name: Tioguanine


subject: CHEBI:9555


subject: CHEBI:9555


subject: UNII:DQ448MW7KS

subject_name: Palivizumab

object_name: congenital heart disease


subject: UNII:DQ448MW7KS

object_name: bronchopulmonary dysplasia


subject: UNII:DQ448MW7KS

object_name: Bronchopulmonary Dysplasia, AE


subject: UNII:DQ448MW7KS

object_name: Premature birth


subject: UNII:DQ448MW7KS

object_name: premature birth (history)


subject: UMLS:C0672594

subject_name: MEDI 493


subject: UMLS:C0672594


subject: UMLS:C0672594


subject: UMLS:C0672594


subject: UMLS:C0672594


subject: CHEBI:84331

object_name: diabetes mellitus


subject: UMLS:C1440867

subject_name: lactoferrin, bovine

object_name: colorectal cancer


subject: UMLS:C1440867

object_name: colorectal carcinoma


subject: UMLS:C1440867

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C1440867

object_name: Oral Complication of Chemotherapy


subject: UMLS:C1440867

object_name: Dysgeusia, CTCAE


subject: UMLS:C4085975

subject_name: Lacutamab

object_name: Mycosis fungoides/Sezary syndrome


subject: UMLS:C4085975

object_name: T-Cell Lymphoma


subject: UMLS:C4085975

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: UMLS:C4085975

object_name: primary cutaneous T-cell lymphoma


subject: PUBCHEM.COMPOUND:368860

subject_name: Becatecarin

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:368860

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:368860

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Stage IIIB Breast Carcinoma


subject: PUBCHEM.COMPOUND:368860

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: PUBCHEM.COMPOUND:368860

object_name: male breast carcinoma


subject: PUBCHEM.COMPOUND:368860

object_name: Breast cancer recurrent


subject: CHEBI:90217

subject_name: Quizartinib

object_name: Refractory Acute Leukemia


subject: CHEBI:90217

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: UNII:5TAA004E22

subject_name: Sargramostim

object_name: graft versus host disease


subject: UNII:5TAA004E22

object_name: myeloproliferative neoplasm


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:82663

subject_name: elemental iron

object_name: iron deficiency anemia


subject: HMDB:HMDB0015666

subject_name: Lornoxicam

object_name: Renal Colic, CTCAE


subject: HMDB:HMDB0015666

object_name: renal colic


subject: CHEBI:15379

subject_name: Oxygen

object_name: lumbar disc herniation


subject: UMLS:C5439915

subject_name: EpiVacCorona


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Locally Advanced Gastric Adenocarcinoma


subject: UNII:DPT0O3T46P

object_name: Clinical Stage IV Gastric Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Clinical Stage III Gastric Cancer AJCC v8


subject: UNII:DPT0O3T46P

object_name: Squamous cell carcinoma of head and neck metastatic


subject: UNII:DPT0O3T46P

object_name: Unresectable Malignant Solid Neoplasm


subject: UNII:DPT0O3T46P

object_name: Refractory Lung Non-Small Cell Carcinoma


subject: UNII:DPT0O3T46P

object_name: Metastatic gastric adenocarcinoma


subject: CHEBI:90863

subject_name: Sonidegib

object_name: Locally Advanced Urothelial Carcinoma


subject: CHEBI:90863


subject: CHEBI:90863

object_name: Stage IV Lung Cancer AJCC v8


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863

object_name: Locally Advanced Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:90863

object_name: Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8


subject: CHEBI:90863

object_name: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90863

object_name: Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8


subject: CHEBI:90863

object_name: Squamous cell carcinoma of head and neck recurrent


subject: CHEBI:90863


subject: CHEBI:90863


subject: CHEBI:90863

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:90863

object_name: Clinical Stage III Cutaneous Melanoma AJCC v8


subject: CHEBI:90863

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:90863

object_name: Metastatic Gastroesophageal Junction Adenocarcinoma


subject: CHEBI:90863


subject: CHEBI:90863

object_name: Metastatic Lung Non-Small Cell Carcinoma


subject: CHEBI:90863

object_name: Metastatic urothelial carcinoma


subject: CHEBI:90863


subject: CHEBI:90863

object_name: Unresectable Melanoma


subject: CHEBI:90863

object_name: metastatic melanoma


subject: UMLS:C4721867

object_name: human papilloma virus infection


subject: UMLS:C0796508

subject_name: IDEC In2B8

object_name: Recurrent Grade 2 Follicular Lymphoma


subject: UMLS:C0796508

object_name: Recurrent Grade 1 Follicular Lymphoma


subject: UMLS:C0796508

object_name: Recurrent Grade 3 Follicular Lymphoma


subject: UMLS:C0796508

object_name: B-cell small lymphocytic lymphoma recurrent


subject: UMLS:C0796508

object_name: Marginal zone lymphoma recurrent


subject: UMLS:C0796508

object_name: splenic marginal zone lymphoma


subject: UMLS:C0796508

object_name: nodal marginal zone B-cell lymphoma


subject: UMLS:C0796508

object_name: MALT lymphoma


subject: UMLS:C0796508

object_name: Waldenstrom macroglobulinemia


subject: UNII:HM5641GA6F

subject_name: Oprelvekin


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: UNII:HM5641GA6F


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: PR:000001366


subject: UMLS:C0537668

subject_name: Neumega


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0537668


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: UMLS:C0879283


subject: CHEMBL.COMPOUND:CHEMBL5095385

subject_name: NANRILKEFUSP ALFA

object_name: head and neck squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: triple-negative breast carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: Triple-Negative Breast Cancer Finding


subject: CHEMBL.COMPOUND:CHEMBL5095385


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: microsatellite instability high


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: non-small cell lung carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: skin squamous cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: biliary tract cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: trabecular adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: cutaneous neuroendocrine carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: nonpapillary renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: clear cell renal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: renal cell adenocarcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: renal cell carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: cervical cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: cervical carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: thyroid tumor


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: thyroid gland carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: thyroid cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: Stomach cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: gastric cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: bladder tumor


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: urinary bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: urinary bladder cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: childhood bladder carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: ovarian cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: ovarian neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: ovarian carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: thymus cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: Mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: mesothelial neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: malignant mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: anus cancer


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: anal carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5095385

object_name: melanoma


subject: UMLS:C5417804

subject_name: RLI 15

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5417804

object_name: triple-negative breast carcinoma


subject: UMLS:C5417804

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5417804


subject: UMLS:C5417804

object_name: microsatellite instability high


subject: UMLS:C5417804

object_name: non-small cell lung carcinoma


subject: UMLS:C5417804

object_name: skin squamous cell carcinoma


subject: UMLS:C5417804

object_name: biliary tract cancer


subject: UMLS:C5417804

object_name: liver carcinoma


subject: UMLS:C5417804

object_name: trabecular adenocarcinoma


subject: UMLS:C5417804

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C5417804

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5417804

object_name: clear cell renal carcinoma


subject: UMLS:C5417804

object_name: renal cell adenocarcinoma


subject: UMLS:C5417804

object_name: renal cell carcinoma


subject: UMLS:C5417804

object_name: cervical cancer


subject: UMLS:C5417804

object_name: cervical carcinoma


subject: UMLS:C5417804

object_name: thyroid tumor


subject: UMLS:C5417804

object_name: thyroid gland carcinoma


subject: UMLS:C5417804

object_name: thyroid cancer


subject: UMLS:C5417804

object_name: Stomach cancer


subject: UMLS:C5417804

object_name: gastric cancer


subject: UMLS:C5417804

object_name: bladder tumor


subject: UMLS:C5417804

object_name: urinary bladder carcinoma


subject: UMLS:C5417804

object_name: urinary bladder cancer


subject: UMLS:C5417804

object_name: childhood bladder carcinoma


subject: UMLS:C5417804

object_name: ovarian cancer


subject: UMLS:C5417804

object_name: ovarian neoplasm


subject: UMLS:C5417804

object_name: ovarian carcinoma


subject: UMLS:C5417804

object_name: thymus cancer


subject: UMLS:C5417804

object_name: Mesothelioma


subject: UMLS:C5417804

object_name: mesothelial neoplasm


subject: UMLS:C5417804

object_name: malignant mesothelioma


subject: UMLS:C5417804

object_name: anus cancer


subject: UMLS:C5417804

object_name: anal carcinoma


subject: UMLS:C5417804

object_name: melanoma


subject: UNII:DPT0O3T46P

object_name: microsatellite instability high


subject: UNII:DPT0O3T46P

object_name: thyroid gland carcinoma


subject: UNII:DPT0O3T46P

object_name: thyroid cancer


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UNII:DPT0O3T46P


subject: UMLS:C0751598

subject_name: Alferon

object_name: Melanoma recurrent


subject: UMLS:C0751598

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C0751598

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C0751598

object_name: metastatic melanoma


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: UMLS:C1328728


subject: CHEBI:232584

object_name: High grade glioma


subject: CHEBI:232584

object_name: malignant glioma


subject: CHEBI:232584

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:232584

object_name: Platinum-Resistant Ovarian Carcinoma


subject: CHEBI:232584

object_name: Platinum-Resistant Urothelial Carcinoma


subject: UMLS:C5418096

subject_name: DNMT1 Inhibitor NTX-301


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C5418096


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: UMLS:C0919079


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:72564


subject: UNII:4Y05SI704S

subject_name: SOMAVARATAN

object_name: hereditary endocrine growth disease


subject: UMLS:C4519725

subject_name: Somavaratan


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: head and neck squamous cell carcinoma


subject: UMLS:C2351194

object_name: interstitial cystitis


subject: UNII:C9H2L21V7U

subject_name: SMOFlipid

object_name: Prematurity of fetus


subject: UNII:C9H2L21V7U

object_name: Premature infant


subject: UNII:RFO6IL3D3M

subject_name: (R)-Naltrexone methylbromide

object_name: Constipation


subject: UNII:RFO6IL3D3M

object_name: Colonic inertia


subject: CHEBI:136007

subject_name: methylnaltrexone


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: chronic neutrophilic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:95165


subject: CHEBI:50131

subject_name: Decitabine


subject: CHEBI:91407

subject_name: Momelotinib

object_name: Myelodysplasia


subject: CHEBI:91407


subject: CHEBI:91407

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:91407

object_name: chronic myelomonocytic leukemia


subject: CHEBI:71954

subject_name: Buparlisib

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:28748

subject_name: Doxorubicin

object_name: small cell lung carcinoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: malignant soft tissue neoplasm


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:44424639

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:44424639

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:44424639

object_name: malignant pancreatic neoplasm


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: Acne inversa


subject: UMLS:C1170231

subject_name: Dryvax

object_name: smallpox


subject: UMLS:C2698199

subject_name: Lovaxin-C

object_name: cervical intraepithelial neoplasia


subject: UMLS:C2698199

object_name: dysplasia of cervix


subject: CHEBI:41879

object_name: metastatic prostate carcinoma


subject: CHEBI:41879

object_name: prostate adenocarcinoma


subject: UNII:L500PR95QA

subject_name: METRONIDAZOLE PHOSPHATE


subject: UNII:L500PR95QA


subject: CHEBI:6909

subject_name: Metronidazole


subject: CHEBI:6909


subject: DRUGBANK:DB14101

subject_name: Soy isoflavones

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Stage IB Breast Cancer AJCC v7


subject: DRUGBANK:DB14101

object_name: Breast cancer stage II


subject: DRUGBANK:DB14101

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: DRUGBANK:DB14101

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Stage IA Breast Cancer AJCC v7


subject: DRUGBANK:DB14101

object_name: stage IA breast cancer


subject: DRUGBANK:DB14101

object_name: Stage IIIB Breast Carcinoma


subject: DRUGBANK:DB14101

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: DRUGBANK:DB14101

object_name: Stage IIIA Breast Carcinoma


subject: DRUGBANK:DB14101

object_name: ductal breast carcinoma in situ


subject: DRUGBANK:DB14101

object_name: lobular breast carcinoma in situ


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Polyarthritis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UNII:63J9EQ81YC

object_name: Primary Insomnia


subject: UNII:63J9EQ81YC

object_name: Secondary Insomnia


subject: CHEBI:10125

subject_name: Zolpidem


subject: CHEBI:44915

subject_name: Propofol

object_name: Anesthetics adverse reaction


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:177770

subject_name: Ganetespib

object_name: Solid Neoplasm


subject: CHEBI:139072

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:139072

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: adverse effect


subject: CHEBI:4466

object_name: Adverse effects


subject: CHEBI:4466

object_name: Adverse reactions


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: UNII:7N8K34P2XH


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: bacterial endocarditis


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: DRUGBANK:DB10640

subject_name: Beet

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:16867

subject_name: D-Methionine


subject: CHEBI:135919

subject_name: Nesiritide

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:135919

object_name: obesity


subject: CHEBI:135919

object_name: Obesity, CTCAE


subject: CHEBI:135919

object_name: cardiovascular disorder


subject: CHEBI:135919

object_name: type 2 diabetes mellitus


subject: CHEBI:135919

object_name: Diabetes


subject: CHEBI:135919

object_name: diabetes mellitus


subject: UMLS:C3273725

object_name: prostate carcinoma


subject: UMLS:C3273725

object_name: prostate cancer


subject: UNII:XC0UT08SNJ

object_name: acute myeloid leukemia by FAB classification


subject: UNII:XC0UT08SNJ

object_name: acute myeloid leukemia


subject: UNII:XC0UT08SNJ

object_name: myelodysplastic syndrome with excess blasts-2


subject: UNII:54T74394F8

subject_name: IADADEMSTAT


subject: UNII:54T74394F8


subject: UNII:54T74394F8


subject: MESH:C000730035

subject_name: iadademstat


subject: MESH:C000730035


subject: MESH:C000730035


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:192842

subject_name: Methoxyamine

object_name: unspecified adult solid tumor, protocol specific


subject: PUBCHEM.COMPOUND:165152355

subject_name: Bivamelagon

object_name: Hypothalamic obesity


subject: UNII:NO1Y8WRA8N

subject_name: BIVAMELAGON


subject: UMLS:C5909079


subject: PUBCHEM.COMPOUND:16760419

subject_name: Etoposide phosphate

object_name: Stage III Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Stage IV Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:16760419

object_name: Childhood Nodular Lymphocyte Predominant Hodgkin Lymphoma


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:32296

subject_name: vinorelbine L-tartrate


subject: CHEBI:32296


subject: CHEBI:32296


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: PUBCHEM.COMPOUND:16051941


subject: CHEBI:53750

subject_name: vinorelbine D-tartrate


subject: CHEBI:53750


subject: CHEBI:53750


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: PUBCHEM.COMPOUND:44424639


subject: PUBCHEM.COMPOUND:44424639


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:93786


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: gastroesophageal cancer


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: spinal muscular atrophy


subject: CHEBI:41500

object_name: proximal spinal muscular atrophy


subject: UMLS:C5784997

subject_name: FGFR3 Inhibitor LOXO-435

object_name: Neoplasm Metastasis


subject: UMLS:C5784997

object_name: bladder tumor


subject: UMLS:C5784997

object_name: ureter cancer


subject: UMLS:C5784997

object_name: ureter neoplasm


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB


subject: UNII:DLE8519RWM


subject: UNII:DLE8519RWM


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: CHEBI:7454

subject_name: Nalbuphine

object_name: no feeling or sensation of skin


subject: CHEBI:7454

object_name: Sensory Loss


subject: CHEBI:4672

subject_name: Docetaxel

object_name: oral cavity squamous cell carcinoma


subject: CHEBI:4672

object_name: pancreatic ductal adenocarcinoma


subject: UNII:HT4MAJ8SLE

subject_name: MAVROSTOBART


subject: UNII:HT4MAJ8SLE

object_name: non-small cell lung carcinoma


subject: UMLS:C5783864

subject_name: Anti-CD73 Monoclonal Antibody PT199


subject: UMLS:C5783864


subject: GTOPDB:9592

subject_name: tislelizumab


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: preeclampsia


subject: UMLS:C3883362

subject_name: Programmed Death Receptor-1 Blocking Antibody

object_name: Childhood Solid Neoplasm


subject: UMLS:C3883362

object_name: Adult Solid Neoplasm


subject: UMLS:C3883362

object_name: Solid Neoplasm


subject: UNII:CGA81G3KR5

subject_name: PUCOTENLIMAB

object_name: rectal carcinoma


subject: UNII:CGA81G3KR5

object_name: rectal cancer


subject: UNII:CGA81G3KR5

object_name: Childhood Rectal Carcinoma


subject: UMLS:C5205493

subject_name: Pucotenlimab


subject: UMLS:C5205493


subject: UMLS:C5205493


subject: CHEBI:40279

subject_name: Allopurinol

object_name: High Grade Lymphoma


subject: CHEBI:40279

object_name: adult acute lymphoblastic leukemia


subject: UMLS:C1314420

subject_name: INJECTION, RASBURICASE, 0.5 MG ADMINISTERED


subject: UMLS:C1314420


subject: UNII:08GY9K1EUO

subject_name: Rasburicase


subject: UNII:08GY9K1EUO


subject: UMLS:C0338290


subject: UMLS:C0338290


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:73727

object_name: breast disorder


subject: CHEBI:73727

object_name: Childhood Breast Carcinoma


subject: CHEBI:73727

object_name: breast carcinoma


subject: CHEBI:73727

object_name: breast cancer


subject: CHEBI:73727

object_name: breast neoplasm


subject: CHEBI:73727

object_name: Fibroadenoma


subject: CHEBI:73727

object_name: Fibroadenoma, breast, Female


subject: UNII:5OGS5K699E

subject_name: Merestinib


subject: UNII:5OGS5K699E


subject: UNII:5OGS5K699E


subject: UNII:5OGS5K699E

object_name: Metastatic malignant neoplasm to bone


subject: UNII:089658A12D

subject_name: Guselkumab

object_name: juvenile idiopathic arthritis


subject: CHEBI:7772

subject_name: omeprazole

object_name: developmental and epileptic encephalopathy, 14


subject: CHEBI:77260

subject_name: Omeprazole


subject: CHEBI:50634

object_name: Fibrolipoma of filum terminale


subject: CHEBI:50634

object_name: diastematomyelia


subject: CHEBI:50634

object_name: primary tethered cord syndrome


subject: CHEBI:50634

object_name: Tethered cord


subject: CHEBI:50634

object_name: lipomyelomeningocele


subject: CHEBI:50634

object_name: Dermal Sinus


subject: CHEBI:50634

object_name: neoplasm


subject: CHEBI:50634

object_name: Tumor Mass


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:27690


subject: CHEBI:29235

object_name: chronic graft versus host disease


subject: CHEBI:18276

subject_name: Hydrogen


subject: UMLS:C0885426

subject_name: Hydrogen, Homeopathic preparation


subject: CHEMBL.COMPOUND:CHEMBL4297766

subject_name: HYDROGEN


subject: CHEBI:60799

subject_name: Esketamine

object_name: pain agnosia


subject: CHEBI:60799

object_name: Pain insensitivity


subject: CHEBI:60799

object_name: acute pain due to trauma


subject: CHEBI:60799

object_name: services source emergency medical services (ambulance)


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C1541489

object_name: pancreatic neoplasm


subject: UMLS:C1541489

object_name: exocrine pancreatic carcinoma


subject: UMLS:C1541489

object_name: malignant pancreatic neoplasm


subject: CHEBI:151315

subject_name: Heparin

object_name: viral pneumonia


subject: KEGG.COMPOUND:C00374


subject: CHEBI:93626

subject_name: Melperone

object_name: Parkinson disease


subject: CHEBI:93626

object_name: psychosis


subject: CHEBI:30314

subject_name: Lipoic acid

object_name: peripheral nervous system disorder


subject: CHEBI:30314

object_name: neuropathy


subject: CHEBI:43796

subject_name: (S)-lipoic acid


subject: CHEBI:43796


subject: CHEBI:16494

subject_name: thioctic acid


subject: CHEBI:16494


subject: CHEBI:2666

subject_name: Amitriptyline

object_name: Post-Operative Pain


subject: UNII:2LHZ9ZC3YO

subject_name: Tolinapant

object_name: acute myeloid leukemia by FAB classification


subject: UNII:2LHZ9ZC3YO

object_name: acute myeloid leukemia


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Childhood Ganglioneuroblastoma


subject: CHEBI:31355

object_name: ganglioneuroblastoma


subject: CHEBI:31355

object_name: Localized Resectable Neuroblastoma


subject: CHEBI:31355

object_name: Localized Unresectable Neuroblastoma


subject: CHEBI:85078

subject_name: Dapagliflozin

object_name: diabetic ketoacidosis


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Rotator cuff tear


subject: CHEBI:74705

object_name: Rotator Cuff Injuries


subject: CHEBI:74705

object_name: shoulder impingement syndrome


subject: CHEBI:74705

object_name: Coracohumeral Impingement Syndrome


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: CHEBI:4877

subject_name: Ethambutol

object_name: pulmonary tuberculosis


subject: CHEBI:63584

subject_name: Cabazitaxel

object_name: head and neck squamous cell carcinoma


subject: CHEBI:31355

object_name: Stage IIIC Esophageal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIA Esophageal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIB Esophageal Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIA Esophagus Carcinoma


subject: CHEBI:31355

object_name: Stage IIB Esophageal Carcinoma


subject: CHEBI:31355

object_name: malignant neoplasm of cervical esophagus


subject: CHEBI:31355

object_name: malignant neoplasm of thoracic esophagus


subject: CHEBI:177770

subject_name: Ganetespib


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:177770


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UMLS:C4053669

object_name: castration-resistant prostate carcinoma


subject: UMLS:C4053669

object_name: metastatic prostate carcinoma


subject: GTOPDB:10492

subject_name: envafolimab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:10492

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: UNII:ES1M06M6QH


subject: UNII:ES1M06M6QH


subject: UMLS:C4329339


subject: UMLS:C4329339


subject: HMDB:HMDB0255819

subject_name: Nusinersen

object_name: spinal muscular atrophy, type III


subject: HMDB:HMDB0255819

object_name: spinal muscular atrophy, type II


subject: HMDB:HMDB0255819

object_name: Neuromuscular Manifestations


subject: HMDB:HMDB0255819

object_name: Minor Salivary Gland Sclerosing Microcystic Adenocarcinoma


subject: UNII:76RS4S2ET1

subject_name: Risdiplam

object_name: proximal spinal muscular atrophy


subject: UNII:76RS4S2ET1


subject: UNII:76RS4S2ET1


subject: UNII:76RS4S2ET1


subject: UNII:76RS4S2ET1


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: Hepatic impairment


subject: UMLS:C5666976

subject_name: Oncolytic Virus RT-01

object_name: viral disease


subject: UMLS:C5666976

object_name: T-Cell Lymphoma


subject: UMLS:C5666976

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: UNII:TK02X14ASJ

subject_name: RIVOCERANIB MESYLATE

object_name: Plexosarcoma


subject: UNII:5S371K6132

subject_name: Rivoceranib


subject: UMLS:C5553037

subject_name: rivoceranib mesylate


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:9995208

subject_name: Estetrol

object_name: Childhood Breast Carcinoma


subject: PUBCHEM.COMPOUND:9995208

object_name: breast carcinoma


subject: PUBCHEM.COMPOUND:9995208

object_name: breast cancer


subject: CHEBI:7915

subject_name: Pantoprazole

object_name: obstructive sleep apnea syndrome


subject: UMLS:C4086499

subject_name: Huaier Extract Granule

object_name: ovarian cancer


subject: UMLS:C4086499

object_name: ovarian neoplasm


subject: UMLS:C4086499

object_name: ovarian carcinoma


subject: UNII:6TYS9VV2WM

object_name: B-cell neoplasm


subject: UMLS:C5417881

subject_name: Volrustomig

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C5417881

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C5417881

object_name: sarcoma


subject: UMLS:C5417881

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C5417881

object_name: soft tissue sarcoma


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: Childhood Solid Neoplasm


subject: UMLS:C0013227

object_name: Adult Solid Neoplasm


subject: UMLS:C0013227

object_name: Solid Neoplasm


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: UMLS:C1254351


subject: UMLS:C4744415

subject_name: PTPN11 Inhibitor RMC-4630


subject: UMLS:C4744415


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Stage IV Gallbladder Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage IIB Gallbladder Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: gallbladder cancer


subject: UNII:PQX0D8J21J

object_name: Stage IIA Gallbladder Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage III Gallbladder Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: Stage 0 Gallbladder Cancer AJCC v8


subject: UNII:PQX0D8J21J

object_name: gallbladder carcinoma


subject: UNII:PQX0D8J21J

object_name: cholangiocarcinoma of the extrahepatic bile duct


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: UMLS:C0879636


subject: CHEBI:77562

subject_name: rac-crizotinib


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:77562


subject: CHEBI:64310

subject_name: Crizotinib


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: CHEBI:64310


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:49668

subject_name: Gefitinib


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49668


subject: CHEBI:49603

subject_name: Lapatinib


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: CHEBI:49603


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:230796

subject_name: Orvepitant

object_name: Depressed mood


subject: CHEBI:94708

subject_name: Diacerein

object_name: Ocular surface disease


subject: CHEBI:94708

object_name: Ocular Surface Disease, CTCAE


subject: CHEBI:3638

subject_name: Chloroquine

object_name: HIV infection


subject: CHEBI:6801

subject_name: Metformin

object_name: Childhood Glioblastoma


subject: CHEBI:6801

object_name: adult glioblastoma


subject: CHEBI:90936

subject_name: Alectinib

object_name: Metastatic non-small cell lung cancer


subject: CHEBI:93775

subject_name: Amethopterin

object_name: Pediatric Crohn's disease


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: UMLS:C3896902

object_name: acute myeloid leukemia


subject: UMLS:C2825026

subject_name: Unfractionated Heparin [EPC]

object_name: acute kidney failure


subject: UMLS:C2825026

object_name: Acute Kidney Injury, CTCAE


subject: UMLS:C2825026

object_name: acute respiratory distress syndrome


subject: CHEBI:151315

subject_name: Heparin


subject: UNII:DA709Q5020

subject_name: zalutumumab

object_name: squamous cell carcinoma


subject: UMLS:C1831978


subject: CHEBI:9622

subject_name: Tolterodine

object_name: obstructive sleep apnea syndrome


subject: UMLS:C3661049

object_name: cocaine use disorder


subject: UNII:52Y8L60CR7

object_name: Solid Neoplasm


subject: CHEBI:52970

object_name: Sepsis


subject: CHEBI:52970

object_name: Sepsis, CTCAE


subject: CHEBI:60899


subject: CHEBI:60899


subject: CHEBI:177490


subject: CHEBI:177490


subject: CHEBI:167578


subject: CHEBI:167578


subject: CHEBI:64183

subject_name: Ubiquinol


subject: CHEBI:64183


subject: CHEBI:8228

subject_name: Pioglitazone

object_name: Prediabetes


subject: CHEBI:8228

object_name: glucose intolerance


subject: CHEBI:8228

object_name: Impaired glucose tolerance


subject: CHEBI:15367

subject_name: Tretinoin

object_name: triple-negative breast carcinoma


subject: CHEBI:15367

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:12989

subject_name: toripalimab


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: DRUGBANK:DB11247

subject_name: Sambucus nigra flowering top


subject: UMLS:C1446826

subject_name: Sambucus nigra antigen


subject: UMLS:C0302908

subject_name: Liquid substance


subject: CHEBI:34945

object_name: Functional constipation


subject: UNII:7662KG2R6K

subject_name: Lubiprostone


subject: UMLS:C5555012

subject_name: Anti-PD-1 Monoclonal Antibody GNR-051

object_name: non-small cell lung carcinoma


subject: UMLS:C5555012

object_name: renal cell carcinoma


subject: UMLS:C5555012

object_name: melanoma


subject: CHEBI:31236

subject_name: Aripiprazole


subject: UNII:Q40Q9N063P

subject_name: ACETIC ACID

object_name: cervical cancer


subject: UNII:Q40Q9N063P

object_name: cervical carcinoma


subject: CHEBI:40410

subject_name: N-acetylglycine


subject: CHEBI:40410


subject: UMLS:C1550049

subject_name: Acetic Acid - Specimen Additive


subject: UMLS:C1550049


subject: UMLS:C0000985

subject_name: Acetic Acids


subject: UMLS:C0000985


subject: CHEBI:15366

subject_name: Acetic acid


subject: CHEBI:15366


subject: CHEBI:8452

subject_name: Proflavine


subject: UMLS:C4744344

subject_name: Anti-HER2 Antibody-drug Conjugate

object_name: colorectal cancer


subject: UMLS:C4744344

object_name: colorectal carcinoma


subject: UMLS:C4744344

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C0939788

subject_name: Zometa

object_name: Mesothelioma


subject: UMLS:C0939788

object_name: mesothelial neoplasm


subject: UMLS:C0939788

object_name: malignant mesothelioma


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: CHEBI:46557


subject: UNII:5S371K6132

subject_name: Rivoceranib

object_name: nasopharyngeal neoplasm


subject: CHEMBL.COMPOUND:CHEMBL2108924

subject_name: CINNAMON

object_name: Prediabetes


subject: CHEMBL.COMPOUND:CHEMBL2108924

object_name: hyperglycemia


subject: UMLS:C0939899

subject_name: cinnamon preparation


subject: UMLS:C0939899


subject: CHEBI:131902

object_name: malignant glioma


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: MALT lymphoma


subject: CHEBI:89324

object_name: follicular lymphoma


subject: CHEBI:89324

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:89324

object_name: marginal zone lymphoma


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UMLS:C3537249


subject: UNII:E53VN70K2X

object_name: hepatitis B


subject: UNII:E53VN70K2X

object_name: chronic hepatitis B virus infection


subject: CHEMBL.COMPOUND:CHEMBL4594459


subject: CHEMBL.COMPOUND:CHEMBL4594459


subject: CHEBI:232469

object_name: Plasma cell myeloma recurrent


subject: CHEBI:232469

object_name: Plasma cell myeloma refractory


subject: CHEBI:9316

subject_name: Sufentanil

object_name: Labor Pain


subject: CHEBI:6456

subject_name: Lidocaine


subject: CHEBI:8452

object_name: Barrett esophagus


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Chronic low back pain


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: UNII:81XK02929C

object_name: bowel; stricture


subject: UNII:81XK02929C

object_name: inflammatory bowel disease 1


subject: UNII:81XK02929C

object_name: Crohn disease


subject: UNII:81XK02929C

object_name: inflammatory bowel disease


subject: CHEBI:35666

subject_name: thiopurine


subject: CHEBI:35666


subject: CHEBI:35666


subject: CHEBI:35666


subject: CHEBI:2208

subject_name: Mercaptopurine


subject: CHEBI:2208


subject: CHEBI:2208


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Metastatic Renal Cell Carcinoma


subject: CHEBI:79699

object_name: Metastatic Renal Cell Cancer


subject: CHEBI:5109

subject_name: Fluocinonide

object_name: psoriasis


subject: CHEBI:38562

subject_name: Fluvastatin

object_name: inherited lipid metabolism disorder


subject: CHEBI:38562

object_name: Dyslipidemia


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Neurocognitive impairment, mild


subject: UNII:6O85FK9I0X

subject_name: Vatiquinone

object_name: Friedreich ataxia


subject: UNII:6O85FK9I0X

object_name: Friedreich ataxia 1


subject: CHEBI:91432

subject_name: Brivanib

object_name: neoplasm


subject: CHEBI:91432

object_name: Neoplasm Metastasis


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM

object_name: Heartburn


subject: UNII:1AL13B11R4

subject_name: Pantoprazole magnesium


subject: UMLS:C1576770

subject_name: pantoprazole magnesium


subject: CHEBI:7773

subject_name: Ondansetron

object_name: viral disease


subject: CHEBI:6950

subject_name: Mirtazapine

object_name: Addictive amphetamine use


subject: CHEBI:6950

object_name: heroin dependence


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Unresectable Melanoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube carcinosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial endometrioid adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial undifferentiated carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: undifferentiated carcinoma of the corpus uteri


subject: UNII:2S9ZZM9Q9V

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube squamous cell carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Primary peritoneal carcinosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial mixed adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: endometrial mucinous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: mucinous ovarian cancer


subject: UNII:2S9ZZM9Q9V

object_name: cervical carcinosarcoma


subject: UNII:2S9ZZM9Q9V

object_name: female reproductive organ cancer


subject: UNII:2S9ZZM9Q9V

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Platinum-Resistant Ovarian Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: high grade ovarian serous adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: cervical adenosarcoma


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel

object_name: Unresectable Melanoma


subject: MESH:C520255

object_name: fallopian tube carcinosarcoma


subject: MESH:C520255

object_name: fallopian tube endometrioid adenocarcinoma


subject: MESH:C520255

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: MESH:C520255

object_name: fallopian tube adenocarcinoma


subject: MESH:C520255

object_name: peritoneum cancer


subject: MESH:C520255

object_name: endometrial endometrioid adenocarcinoma


subject: MESH:C520255

object_name: endometrium adenocarcinoma


subject: MESH:C520255

object_name: endometrial undifferentiated carcinoma


subject: MESH:C520255

object_name: undifferentiated carcinoma of the corpus uteri


subject: MESH:C520255

object_name: Platinum-Resistant Fallopian Tube Carcinoma


subject: MESH:C520255

object_name: fallopian tube clear cell adenocarcinoma


subject: MESH:C520255

object_name: fallopian tube squamous cell carcinoma


subject: MESH:C520255

object_name: Primary peritoneal carcinosarcoma


subject: MESH:C520255

object_name: fallopian tube serous adenocarcinoma


subject: MESH:C520255

object_name: Primary Peritoneal Undifferentiated Carcinoma


subject: MESH:C520255

object_name: endometrial clear cell adenocarcinoma


subject: MESH:C520255

object_name: fallopian tube mucinous adenocarcinoma


subject: MESH:C520255

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: MESH:C520255

object_name: endometrial serous adenocarcinoma


subject: MESH:C520255

object_name: fallopian tube transitional cell carcinoma


subject: MESH:C520255

object_name: ovarian endometrial cancer


subject: MESH:C520255

object_name: endometrial mixed adenocarcinoma


subject: MESH:C520255

object_name: Clear cell adenocarcinoma of peritoneum


subject: MESH:C520255

object_name: Platinum-Resistant Primary Peritoneal Carcinoma


subject: MESH:C520255

object_name: primary peritoneal serous adenocarcinoma


subject: MESH:C520255

object_name: peritoneal serous adenocarcinoma


subject: MESH:C520255

object_name: endometrial adenosquamous carcinoma


subject: MESH:C520255

object_name: endometrial mucinous adenocarcinoma


subject: MESH:C520255

object_name: ovarian clear cell cancer


subject: MESH:C520255

object_name: Primary Peritoneal Transitional Cell Carcinoma


subject: MESH:C520255

object_name: malignant epithelial tumor of ovary


subject: MESH:C520255

object_name: mucinous ovarian cancer


subject: MESH:C520255

object_name: undifferentiated ovarian carcinoma


subject: MESH:C520255

object_name: ovarian endometrioid adenocarcinoma


subject: MESH:C520255

object_name: Malignant Solid Neoplasm


subject: MESH:C520255

object_name: cervical carcinosarcoma


subject: MESH:C520255

object_name: cervical squamous cell carcinoma


subject: MESH:C520255

object_name: ovarian transitional cell carcinoma


subject: MESH:C520255

object_name: female reproductive organ cancer


subject: MESH:C520255

object_name: ovarian clear cell adenocarcinoma


subject: MESH:C520255

object_name: cervical adenosquamous carcinoma


subject: MESH:C520255

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: MESH:C520255

object_name: Platinum-Resistant Ovarian Carcinoma


subject: MESH:C520255

object_name: high grade ovarian serous adenocarcinoma


subject: MESH:C520255

object_name: cervical adenosarcoma


subject: MESH:C520255

object_name: Primary mucinous adenocarcinoma of ovary


subject: MESH:C520255

object_name: ovarian mucinous adenocarcinoma


subject: MESH:C520255

object_name: ovarian serous adenocarcinoma


subject: MESH:C520255

object_name: carcinosarcoma of the corpus uteri


subject: MESH:C520255

object_name: ovarian carcinosarcoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Unresectable Melanoma


subject: CHEBI:45863

object_name: fallopian tube carcinosarcoma


subject: CHEBI:45863

object_name: fallopian tube adenocarcinoma


subject: CHEBI:45863

object_name: endometrial endometrioid adenocarcinoma


subject: CHEBI:45863

object_name: fallopian tube squamous cell carcinoma


subject: CHEBI:45863

object_name: Primary peritoneal carcinosarcoma


subject: CHEBI:45863

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:45863

object_name: ovarian endometrial cancer


subject: CHEBI:45863

object_name: endometrial mixed adenocarcinoma


subject: CHEBI:45863

object_name: ovarian clear cell cancer


subject: CHEBI:45863

object_name: mucinous ovarian cancer


subject: CHEBI:45863

object_name: cervical carcinosarcoma


subject: CHEBI:45863

object_name: Platinum-Sensitive Ovarian Carcinoma


subject: CHEBI:45863

object_name: high grade ovarian serous adenocarcinoma


subject: CHEBI:45863

object_name: cervical adenosarcoma


subject: CHEBI:135967

subject_name: Casopitant

object_name: Chemotherapy-induced nausea and vomiting


subject: UMLS:C1831798


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Pilonidal disease


subject: DRUGBANK:DB18277

object_name: retinitis pigmentosa


subject: DRUGBANK:DB18277

object_name: retinitis pigmentosa 1


subject: CHEBI:9654

subject_name: Trazodone

object_name: Diabetic Neuralgia


subject: CHEBI:52763


subject: CHEBI:190735

subject_name: Arbaclofen

object_name: multiple sclerosis


subject: CHEBI:2659

subject_name: Aminophylline

object_name: Mountain Sickness


subject: CHEBI:2659

object_name: acute mountain sickness


subject: CHEBI:2659

object_name: altitude sickness


subject: CHEBI:28177

subject_name: Theophylline


subject: CHEBI:28177


subject: CHEBI:28177


subject: UNII:DA43GW06P1

subject_name: Methazolamide


subject: UNII:DA43GW06P1


subject: UNII:DA43GW06P1


subject: CHEBI:6822


subject: CHEBI:6822


subject: CHEBI:6822


subject: CHEBI:42944

subject_name: Galantamine

object_name: Stroke (heart beat)


subject: CHEBI:42944

object_name: Stroke, CTCAE


subject: CHEBI:42944

object_name: aphasia


subject: PUBCHEM.COMPOUND:42615

subject_name: BUSERELIN

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:42615

object_name: prostate cancer


subject: CHEBI:7573

subject_name: Nilutamide


subject: CHEBI:7573


subject: CHEBI:71200

subject_name: Tofacitinib

object_name: JAK-STAT Pathway Deregulation


subject: CHEBI:71200

object_name: Drug usage


subject: CHEBI:71200

object_name: Drug use history


subject: CHEBI:71200

object_name: Encounter due to drug use


subject: CHEBI:5778

subject_name: Hydrochlorothiazide

object_name: Nocturia


subject: UMLS:C2012940

subject_name: tetrahydrocannabinol (medication)

object_name: Cannabis intoxication


subject: CHEBI:66964

subject_name: Dronabinol


subject: CHEBI:52763


subject: UMLS:C5777349

subject_name: bevacizumab ophthalmic

object_name: Branch retinal vein occlusion


subject: PUBCHEM.COMPOUND:135240787

object_name: type 2 diabetes mellitus


subject: UMLS:C5690553


subject: UNII:43K4X7JG75


subject: UNII:41J7ZJ239R

object_name: skin basal cell carcinoma


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: diffuse large B-cell lymphoma


subject: CHEBI:81579

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:81579

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: choroidal neovascularization


subject: UNII:2S9ZZM9Q9V

object_name: choroidal neovascularization (physical finding)


subject: UNII:2S9ZZM9Q9V

object_name: degenerative myopia


subject: CHEBI:443725

subject_name: Fosmidomycin

object_name: malaria


subject: CHEBI:31527

subject_name: Dydrogesterone

object_name: Functional cyst of ovary


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib

object_name: Recurrent Fallopian Tube Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent Primary Peritoneal Carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Breast cancer recurrent


subject: PUBCHEM.COMPOUND:42602260

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: triple-negative breast carcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: HER2/Neu Negative


subject: PUBCHEM.COMPOUND:42602260

object_name: endometrium adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:42602260

object_name: Estrogen Receptor Negative


subject: PUBCHEM.COMPOUND:42602260

object_name: Progesterone Receptor Negative


subject: PUBCHEM.COMPOUND:42602260

object_name: high grade ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage IV Uterine Corpus Cancer


subject: PUBCHEM.COMPOUND:42602260

object_name: Stage III Uterine Corpus Cancer


subject: CHEBI:83766

subject_name: Olaparib


subject: CHEBI:83766


subject: CHEBI:83766


subject: CHEBI:83766


subject: UNII:0BSC3P4H5X

subject_name: Vistusertib


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UNII:0BSC3P4H5X


subject: UMLS:C2826229

object_name: non-small cell lung carcinoma


subject: UMLS:C2000001

object_name: essential hypertension


subject: PUBCHEM.COMPOUND:6012

subject_name: Durandro

object_name: prostate carcinoma


subject: PUBCHEM.COMPOUND:6012

object_name: prostate cancer


subject: CHEBI:139072

object_name: cancer


subject: CHEBI:139072

object_name: neoplasm


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:205919

subject_name: Clobetasol

object_name: Oral Pain


subject: CHEBI:205919

object_name: Oral Pain, CTCAE 5.0


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: obesity


subject: CHEBI:3614

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:3614

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:3614

object_name: morbid obesity


subject: CHEBI:8665

subject_name: Pyridostigmine

object_name: diabetes mellitus


subject: CHEBI:50275

subject_name: Esomeprazole

object_name: peptic esophagitis


subject: CHEBI:50275

object_name: Gastro-esophageal reflux disease with esophagitis


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Disorder of ankle


subject: CHEBI:26710

object_name: Abnormal foot morphology


subject: CHEBI:26710

object_name: Foot Diseases


subject: CHEBI:26710

object_name: cerebral palsy


subject: CHEMBL.COMPOUND:CHEMBL2108893

subject_name: ALFIMEPRASE

object_name: thrombophilia due to thrombin defect


subject: CHEMBL.COMPOUND:CHEMBL2108893

object_name: Venous thrombosis after immobility


subject: UMLS:C1097921

subject_name: alfimeprase


subject: UMLS:C1097921


subject: UMLS:C5237726

subject_name: Anti-CD20 Monoclonal Antibody MIL62


subject: CHEBI:6888

subject_name: Methylprednisolone

object_name: heart failure; with decompensation


subject: UMLS:C5854656

subject_name: STING Agonist CRD3874

object_name: malignant soft tissue neoplasm


subject: UMLS:C5854656

object_name: sarcoma


subject: UMLS:C5854656

object_name: trabecular adenocarcinoma


subject: UMLS:C5854656

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:R048696O9L

subject_name: Iopofosine I-131

object_name: plasma cell myeloma


subject: UMLS:C5575080


subject: MESH:C433226

subject_name: twinrix

object_name: Harmful pattern of substance use


subject: MESH:C433226

object_name: substance abuse


subject: MESH:C433226

object_name: schizoaffective disorder


subject: MESH:C433226

object_name: schizophrenia 18


subject: MESH:C433226

object_name: schizophrenia


subject: MESH:C433226

object_name: bipolar disorder


subject: MESH:C433226

object_name: HIV infection


subject: MESH:C433226

object_name: Depressed mood


subject: MESH:C433226

object_name: Cancer patients and suicide and depression


subject: MESH:C433226

object_name: Depressed - symptom


subject: MESH:C433226

object_name: Depression, CTCAE


subject: CHEBI:18258

subject_name: Liothyronine

object_name: type 2 diabetes mellitus


subject: CHEBI:18258

object_name: Insulin resistance


subject: CHEBI:18258

object_name: diabetes mellitus


subject: CHEBI:18258

object_name: Glucose metabolism abnormal


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: cancer


subject: PUBCHEM.COMPOUND:73151030

object_name: neoplasm


subject: CHEBI:2549

subject_name: Albuterol

object_name: multiple sclerosis


subject: CHEBI:2549

object_name: Autoimmunity


subject: UNII:5M691HL4BO

subject_name: glatiramer acetate


subject: UMLS:C0662900

object_name: adult lymphoma


subject: UMLS:C0662900

object_name: lymphoma


subject: UMLS:C0662900

object_name: pediatric lymphoma


subject: UMLS:C0662900

object_name: Hodgkin Disease


subject: UMLS:C0662900

object_name: plasma cell myeloma


subject: UMLS:C0662900

object_name: non-Hodgkin lymphoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Non-small cell carcinoma


subject: CHEBI:31355

object_name: EGFR gene mutation


subject: CHEBI:95021

subject_name: pemetrexed


subject: CHEBI:95021


subject: CHEBI:63724


subject: CHEBI:63724


subject: CHEBI:64816

object_name: fibrosarcoma


subject: CHEBI:64816

object_name: adult liposarcoma


subject: CHEBI:64816

object_name: liposarcoma


subject: CHEBI:64816

object_name: pediatric liposarcoma


subject: CHEBI:64816

object_name: pediatric angiosarcoma


subject: CHEBI:64816

object_name: angiosarcoma


subject: CHEBI:64816

object_name: Adult Angiosarcoma


subject: CHEBI:64816

object_name: adult extraskeletal osteosarcoma


subject: CHEBI:64816

object_name: extraosseous osteosarcoma


subject: CHEBI:64816

object_name: myxofibrosarcoma


subject: CHEBI:64816

object_name: histiocytoma, Angiomatoid fibrous


subject: CHEBI:64816

object_name: Atypical fibroxanthoma of skin


subject: CHEBI:64816

object_name: tumor of adipose tissue


subject: CHEBI:64816

object_name: myoepithelioma


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:5864

subject_name: Ifosfamide


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:71219

subject_name: Pazopanib


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:71219


subject: CHEBI:229764

subject_name: Selinexor


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: CHEBI:229764


subject: UNII:7DT29059VX

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:92043599

subject_name: epoetin alfa

object_name: fetal growth restriction


subject: PUBCHEM.COMPOUND:92043599

object_name: neonatal anemia


subject: CHEBI:81579

subject_name: Erythropoietin


subject: CHEBI:81579


subject: UMLS:C5239084

object_name: Hormone sensitive prostate cancer


subject: UMLS:C5239084

object_name: Castration-Sensitive Prostate Carcinoma


subject: UMLS:C5239084

object_name: metastatic prostate carcinoma


subject: CHEBI:229648

subject_name: Flotufolastat F-18


subject: CHEBI:229648


subject: CHEBI:229648


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: aneurysm


subject: CHEBI:45863

object_name: kidney disorder


subject: CHEBI:146207

subject_name: palytoxin


subject: CHEBI:146207


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: CHEBI:7986


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: insomnia


subject: UMLS:C3540792

object_name: Insomnia, CTCAE 3.0


subject: UMLS:C3540792

object_name: Insomnia, CTCAE 5.0


subject: UMLS:C3540792

object_name: malnutrition


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:25107


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: UMLS:C3714621


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Overweight


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: CHEBI:64356

subject_name: Pregabalin

object_name: Post-Dural Puncture Headaches


subject: UMLS:C4721408

subject_name: Substance with receptor antagonist mechanism of action (substance)

object_name: infertility


subject: UMLS:C0009905

subject_name: Contraceptives, Oral


subject: DRUGBANK:DB17921

object_name: centronuclear myopathy


subject: DRUGBANK:DB17921

object_name: congenital structural myopathy


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: supratentorial cancer


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:47898

subject_name: Epirubicin

object_name: Carcinoma breast stage IV


subject: CHEBI:4315

subject_name: Danazol

object_name: pulmonary fibrosis


subject: CHEBI:4315

object_name: Pulmonary Fibrosis, CTCAE


subject: CHEBI:4315

object_name: Telomere Shortening


subject: CHEBI:4315

object_name: dyskeratosis congenita


subject: PUBCHEM.COMPOUND:2269

object_name: Vomiting, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Vomiting


subject: PUBCHEM.COMPOUND:2269

object_name: Abdominal pain


subject: PUBCHEM.COMPOUND:2269

object_name: Abdominal Pain, CTCAE


subject: PUBCHEM.COMPOUND:2269

object_name: Fever


subject: PUBCHEM.COMPOUND:2269

object_name: Fever symptoms (finding)


subject: PUBCHEM.COMPOUND:2269

object_name: Fever, CTCAE


subject: UMLS:C0812732

subject_name: INJECTION, AZITHROMYCIN, 500 MG ADMINISTERED


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: UMLS:C0812732


subject: CHEBI:2955

subject_name: Azithromycin


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: CHEBI:2955


subject: UNII:37CQ2C7X93

subject_name: Canakinumab

object_name: Still Disease


subject: UMLS:C2718754

subject_name: Ilaris


subject: UNII:25CG88L0BB

subject_name: Brensocatib


subject: CHEBI:131854

subject_name: Fotemustine

object_name: skin melanoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Stage IIIC Lung Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIA Lung Cancer AJCC v8


subject: UNII:28X28X9OKV

object_name: Stage IIIB Lung Cancer AJCC v8


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Non-small cell lung cancer stage III


subject: CHEBI:175901

object_name: Stage III Lung Cancer AJCC v8


subject: CHEBI:175901


subject: CHEBI:175901


subject: CHEBI:175901


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255

object_name: Non-small cell lung cancer stage IIIA


subject: MESH:C520255

object_name: Non-small cell lung cancer stage IIIB


subject: MESH:C520255


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:63724


subject: UNII:3VHF2ZD92J

subject_name: Romosozumab

object_name: Premenopausal idiopathic osteoporosis


subject: PUBCHEM.COMPOUND:118639856

subject_name: IRUPLINALKIB

object_name: non-small cell lung carcinoma


subject: UNII:Z5F65W1YAZ


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: interstitial cystitis


subject: CHEBI:8764

object_name: Painful Bladder Syndrome


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:167450


subject: CHEBI:168396

subject_name: Mycophenolic acid


subject: CHEBI:168396


subject: UNII:G9WJT6RD29

subject_name: Burosumab

object_name: Organoid Nevus Phakomatosis


subject: UNII:G9WJT6RD29

object_name: epidermal nevus syndrome


subject: UMLS:C3896830


subject: UMLS:C3896830


subject: UMLS:C3641796

subject_name: Zirconium Zr 89 DFO-MSTP2109A

object_name: prostate carcinoma


subject: UMLS:C3641796

object_name: prostate cancer


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Infection


subject: PUBCHEM.COMPOUND:23724878

object_name: infectious disease


subject: PUBCHEM.COMPOUND:23724878

object_name: Adverse Event Associated with Infection


subject: PUBCHEM.COMPOUND:23724878

object_name: type 2 diabetes mellitus


subject: PUBCHEM.COMPOUND:23724878

object_name: Diabetes


subject: PUBCHEM.COMPOUND:23724878

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:73005958

subject_name: Carfilzomib

object_name: Disseminated Malignant Neoplasm


subject: PUBCHEM.COMPOUND:73005958

object_name: Embolism, Tumor


subject: PUBCHEM.COMPOUND:73005958

object_name: Neoplasm Metastasis


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UMLS:C1709429


subject: UNII:19J3781LPM

subject_name: Itacitinib


subject: UNII:19J3781LPM


subject: UNII:19J3781LPM


subject: UNII:19J3781LPM

object_name: Solid Neoplasm


subject: UNII:OS7097575K

subject_name: Parsaclisib


subject: UNII:OS7097575K


subject: UNII:OS7097575K


subject: UNII:OS7097575K


subject: UMLS:C3827108


subject: UMLS:C3827108


subject: UMLS:C3827108


subject: UMLS:C3827108


subject: DRUGBANK:DB17567


subject: DRUGBANK:DB17567


subject: DRUGBANK:DB17567


subject: DRUGBANK:DB17567


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:52717

subject_name: Bortezomib


subject: CHEBI:52717


subject: CHEBI:52717


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:63791


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:72690

subject_name: Pomalidomide


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:72690


subject: CHEBI:94559

subject_name: Levocetirizine

object_name: urticaria


subject: CHEBI:94559

object_name: reported urticaria (physical finding)


subject: CHEBI:94559

object_name: Urticaria, CTCAE


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: alcohol-related disorders


subject: UMLS:C0592155

subject_name: Syntocinon


subject: CHEBI:94463

object_name: Drug action (disorder)


subject: CHEBI:63580

subject_name: Ribavirin


subject: UMLS:C0937833

subject_name: AYAHUASCA Extract

object_name: major depressive disorder


subject: PUBCHEM.COMPOUND:49863420

subject_name: ceftolozane

object_name: Complicated intra-abdominal infection


subject: CHEBI:9421

subject_name: Tazobactam


subject: CHEBI:36796

subject_name: duloxetine

object_name: psychosis


subject: CHEBI:48843

subject_name: sodium selenite

object_name: lymphedema


subject: CHEBI:48843

object_name: Lymphedema, CTCAE


subject: CHEBI:48843

object_name: breast neoplasm


subject: UMLS:C4085972


subject: UMLS:C4085972


subject: UMLS:C4085972


subject: UMLS:C4085972

object_name: Advanced cancer


subject: PUBCHEM.COMPOUND:584547

subject_name: Methylprednisolone acetate

object_name: lumbar spinal stenosis


subject: PUBCHEM.COMPOUND:584547

object_name: spinal stenosis


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:150712

subject_name: Hyaluronic acid


subject: CHEBI:150712


subject: CHEMBL.COMPOUND:CHEMBL5314376

subject_name: HYALURONIC ACID


subject: CHEMBL.COMPOUND:CHEMBL5314376


subject: DRUGBANK:DB17475

subject_name: Incomplete Freund's adjuvant

object_name: mucosal melanoma


subject: DRUGBANK:DB17475

object_name: stage IV intraocular melanoma


subject: DRUGBANK:DB17475

object_name: stage IIIA intraocular melanoma


subject: DRUGBANK:DB17475

object_name: stage IIIC intraocular melanoma


subject: DRUGBANK:DB17475

object_name: stage IIIB intraocular melanoma


subject: DRUGBANK:DB17475

object_name: small size posterior uveal melanoma


subject: DRUGBANK:DB17475

object_name: Recurrent Uveal Melanoma


subject: DRUGBANK:DB17475

object_name: Metastatic Uveal Melanoma


subject: UMLS:C2827521

subject_name: Montanide ISA 51 VG


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: UMLS:C2827521


subject: CHEMBL.COMPOUND:CHEMBL2103793

subject_name: AGATOLIMOD SODIUM

object_name: Metastatic Cutaneous Melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: metastatic melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIC melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: uveal melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: iris melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIA melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIB melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIC melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: mucosal melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Melanoma recurrent


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IV intraocular melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIA intraocular melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIC intraocular melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: stage IIIB intraocular melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: small size posterior uveal melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: medium/large size posterior uveal melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Recurrent Uveal Melanoma


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: ocular melanoma with extraocular extension


subject: CHEMBL.COMPOUND:CHEMBL2103793

object_name: Metastatic Uveal Melanoma


subject: UNII:I4Z5C8FM6H

object_name: Metastatic Cutaneous Melanoma


subject: UNII:I4Z5C8FM6H

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:I4Z5C8FM6H

object_name: metastatic melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIC melanoma


subject: UNII:I4Z5C8FM6H

object_name: uveal melanoma


subject: UNII:I4Z5C8FM6H

object_name: iris melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIA melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIB melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIC melanoma


subject: UNII:I4Z5C8FM6H

object_name: mucosal melanoma


subject: UNII:I4Z5C8FM6H

object_name: Melanoma recurrent


subject: UNII:I4Z5C8FM6H

object_name: stage IV intraocular melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIA intraocular melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIC intraocular melanoma


subject: UNII:I4Z5C8FM6H

object_name: stage IIIB intraocular melanoma


subject: UNII:I4Z5C8FM6H

object_name: small size posterior uveal melanoma


subject: UNII:I4Z5C8FM6H

object_name: medium/large size posterior uveal melanoma


subject: UNII:I4Z5C8FM6H

object_name: Recurrent Uveal Melanoma


subject: UNII:I4Z5C8FM6H

object_name: ocular melanoma with extraocular extension


subject: UNII:I4Z5C8FM6H

object_name: Metastatic Uveal Melanoma


subject: DRUGBANK:DB15018

subject_name: Agatolimod

object_name: Metastatic Cutaneous Melanoma


subject: DRUGBANK:DB15018

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: DRUGBANK:DB15018

object_name: metastatic melanoma


subject: DRUGBANK:DB15018

object_name: stage IIC melanoma


subject: DRUGBANK:DB15018

object_name: uveal melanoma


subject: DRUGBANK:DB15018

object_name: iris melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIA melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIB melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIC melanoma


subject: DRUGBANK:DB15018

object_name: mucosal melanoma


subject: DRUGBANK:DB15018

object_name: Melanoma recurrent


subject: DRUGBANK:DB15018

object_name: stage IV intraocular melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIA intraocular melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIC intraocular melanoma


subject: DRUGBANK:DB15018

object_name: stage IIIB intraocular melanoma


subject: DRUGBANK:DB15018

object_name: small size posterior uveal melanoma


subject: DRUGBANK:DB15018

object_name: medium/large size posterior uveal melanoma


subject: DRUGBANK:DB15018

object_name: Recurrent Uveal Melanoma


subject: DRUGBANK:DB15018

object_name: ocular melanoma with extraocular extension


subject: DRUGBANK:DB15018

object_name: Metastatic Uveal Melanoma


subject: UMLS:C0281722

subject_name: gp100 Antigen


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C0281722


subject: UMLS:C1328092

subject_name: Multi-epitope Melanoma Peptide Vaccine

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C1328092

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C1328092

object_name: metastatic melanoma


subject: UMLS:C1328092

object_name: stage IIC melanoma


subject: UMLS:C1328092

object_name: uveal melanoma


subject: UMLS:C1328092

object_name: iris melanoma


subject: UMLS:C1328092

object_name: stage IIIA melanoma


subject: UMLS:C1328092

object_name: stage IIIB melanoma


subject: UMLS:C1328092

object_name: stage IIIC melanoma


subject: UMLS:C1328092

object_name: mucosal melanoma


subject: UMLS:C1328092

object_name: Melanoma recurrent


subject: UMLS:C1328092

object_name: stage IV intraocular melanoma


subject: UMLS:C1328092

object_name: stage IIIA intraocular melanoma


subject: UMLS:C1328092

object_name: stage IIIC intraocular melanoma


subject: UMLS:C1328092

object_name: stage IIIB intraocular melanoma


subject: UMLS:C1328092

object_name: small size posterior uveal melanoma


subject: UMLS:C1328092

object_name: medium/large size posterior uveal melanoma


subject: UMLS:C1328092

object_name: Recurrent Uveal Melanoma


subject: UMLS:C1328092

object_name: ocular melanoma with extraocular extension


subject: UMLS:C1328092

object_name: Metastatic Uveal Melanoma


subject: UMLS:C1510427

subject_name: Recombinant MAGE-3.1 Antigen

object_name: Metastatic Cutaneous Melanoma


subject: UMLS:C1510427

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UMLS:C1510427

object_name: stage IIC melanoma


subject: UMLS:C1510427

object_name: uveal melanoma


subject: UMLS:C1510427

object_name: iris melanoma


subject: UMLS:C1510427

object_name: stage IIIA melanoma


subject: UMLS:C1510427

object_name: stage IIIB melanoma


subject: UMLS:C1510427

object_name: stage IIIC melanoma


subject: UMLS:C1510427

object_name: mucosal melanoma


subject: UMLS:C1510427

object_name: Melanoma recurrent


subject: UMLS:C1510427

object_name: stage IV intraocular melanoma


subject: UMLS:C1510427

object_name: stage IIIA intraocular melanoma


subject: UMLS:C1510427

object_name: stage IIIC intraocular melanoma


subject: UMLS:C1510427

object_name: stage IIIB intraocular melanoma


subject: UMLS:C1510427

object_name: small size posterior uveal melanoma


subject: UMLS:C1510427

object_name: medium/large size posterior uveal melanoma


subject: UMLS:C1510427

object_name: Recurrent Uveal Melanoma


subject: UMLS:C1510427

object_name: ocular melanoma with extraocular extension


subject: UMLS:C1510427

object_name: Metastatic Uveal Melanoma


subject: UMLS:C0338254

subject_name: tyrosinase peptide


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: UMLS:C0338254


subject: GTOPDB:8997

subject_name: ligelizumab

object_name: chronic inducible urticaria


subject: UNII:L8LE0L691T


subject: UMLS:C4041919


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Leg Injuries


subject: CHEBI:3215

object_name: Bone fracture


subject: CHEBI:3215

object_name: Fracture, CTCAE


subject: CHEBI:81916

subject_name: Pancrelipase

object_name: pancreatic neoplasm


subject: CHEBI:81916

object_name: exocrine pancreatic carcinoma


subject: CHEBI:81916

object_name: malignant pancreatic neoplasm


subject: CHEBI:81916

object_name: Pancreatic enzyme abnormality


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UNII:FQ3DRG0N5K


subject: UMLS:C0111046

subject_name: Creon


subject: UMLS:C0111046


subject: UMLS:C0111046


subject: UMLS:C0111046


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: UMLS:C1302030


subject: UMLS:C1302030


subject: UMLS:C1302030


subject: MESH:C000710692

object_name: concussion


subject: MESH:C000710692

object_name: Mild Traumatic Brain Injury


subject: UMLS:C0009331

subject_name: collagen type II

object_name: Arthralgia


subject: UMLS:C0009331

object_name: Joint Pain, CTCAE


subject: UMLS:C4277841

object_name: acute coronary syndrome


subject: UMLS:C1872757

subject_name: Panvac-VF


subject: UMLS:C1872757


subject: UMLS:C1872757


subject: CHEMBL.COMPOUND:CHEMBL2108055

subject_name: TEFIBAZUMAB

object_name: staphylococcus aureus infection


subject: UMLS:C4727756

subject_name: Tefibazumab


subject: CHEBI:15765

subject_name: Levodopa

object_name: oculocutaneous albinism


subject: CHEBI:15765

object_name: albinism


subject: CHEBI:3395

subject_name: carbidopa


subject: CHEBI:3395


subject: CHEBI:94430

subject_name: DL-Carbidopa


subject: CHEBI:94430


subject: CHEBI:39585

subject_name: Carbidopa


subject: CHEBI:39585


subject: CHEBI:78770

subject_name: ethylene glycol monododecyl ether

object_name: neurofibromatosis 1


subject: CHEBI:78770

object_name: neurofibromatosis type 1


subject: CHEBI:46859

subject_name: Polidocanol


subject: CHEBI:46859


subject: UMLS:C1173246

object_name: Neck Carcinoma


subject: UMLS:C1173246

object_name: head and neck neoplasm


subject: UMLS:C1173246

object_name: head and neck cancer


subject: UMLS:C1173246

object_name: Oral Mucositis


subject: UMLS:C1173246

object_name: stomatitis


subject: UMLS:C1173246

object_name: oral mucositis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Riley-Day syndrome


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:17933

subject_name: Calcifediol


subject: CHEBI:17933

object_name: Coronavinae infectious disease


subject: UMLS:C3641087

object_name: mantle cell lymphoma


subject: PR:000015975

subject_name: sperm motility kinase Tcr mutant form

object_name: Vulval intraepithelial neoplasia grade 2


subject: PR:000015975

object_name: squamous cell neoplasm


subject: UMLS:C0034790

subject_name: T-Cell Receptor